相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
Yahui Zhu et al.
HEPATOLOGY (2023)
Drugging p53 in cancer: one protein, many targets
Ori Hassin et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy
Zhipeng Hong et al.
CANCER RESEARCH (2022)
Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis
Chuangen Li et al.
GUT (2022)
High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth
Zhihua Wang et al.
BMC MEDICINE (2022)
Aberrant Cholesterol Metabolism and Wnt/β-Catenin Signaling Coalesce via Frizzled5 in Supporting Cancer Growth
Shaoqin Zheng et al.
ADVANCED SCIENCE (2022)
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes
Zhen Lu et al.
CELL METABOLISM (2022)
Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production
Zaili Yang et al.
CELL METABOLISM (2022)
Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma
Fangzhou Liu et al.
NATURE METABOLISM (2022)
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver
Wenshu Tang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Xiang Zhang et al.
GUT (2021)
Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis
Soo Young Jun et al.
GASTROENTEROLOGY (2021)
The cancer metabolic reprogramming and immune response
Longzheng Xia et al.
MOLECULAR CANCER (2021)
REGULATION AND METABOLIC FUNCTIONS OF mTORC1 AND mTORC2
Angelia Szwed et al.
PHYSIOLOGICAL REVIEWS (2021)
Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation
Wen Ni et al.
MOLECULAR THERAPY (2021)
Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Erwin Danil Yulian et al.
CANCER RESEARCH AND TREATMENT (2021)
Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer
Wen Liu et al.
NATURE COMMUNICATIONS (2021)
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
C. Kalogirou et al.
NATURE COMMUNICATIONS (2021)
DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy
Ruixue Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer
Kai-Li Zhang et al.
THERANOSTICS (2021)
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma
David C. Smith et al.
INVESTIGATIONAL NEW DRUGS (2020)
Mechanisms and regulation of cholesterol homeostasis
Jie Luo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer
Joseph Longo et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling
Qing Liu et al.
ONCOTARGETS AND THERAPY (2020)
Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
Mei-lin Weng et al.
NATURE COMMUNICATIONS (2020)
Cholesterol metabolism: New functions and therapeutic approaches in cancer
Huanji Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells
Zuhier A. Awan et al.
PHARMACEUTICS (2020)
Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer
Linara Gabitova-Cornell et al.
CANCER CELL (2020)
Preclinical toxicology profile of squalene epoxidase inhibitors
Raj Nagaraja et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Lipid metabolism alteration contributes to and maintains the of cancer stem cells
Huangcan Li et al.
THERANOSTICS (2020)
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Binlu Huang et al.
NATURE METABOLISM (2020)
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
Jinrui Zhang et al.
CELL COMMUNICATION AND SIGNALING (2019)
Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
Pieter Goossens et al.
CELL METABOLISM (2019)
Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers
Daniel D. Waller et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage: Possible contribution to cancer cell survival and infiltration
D. Rossin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death
Javier Garcia-Bermudez et al.
NATURE (2019)
AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate
Qilin Gu et al.
SCIENCE (2019)
Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP
Siyuan Jiang et al.
CANCER RESEARCH (2019)
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
Xingzhe Ma et al.
CELL METABOLISM (2019)
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma
Jean-Louis Jouve et al.
JOURNAL OF HEPATOLOGY (2019)
AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux
Tao Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Guangzhen Wu et al.
CELL DEATH & DISEASE (2019)
Membrane Cholesterol Regulates Macrophage Plasticity in Cancer
Antonio Sica et al.
CELL METABOLISM (2019)
Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response
Yonglong Zhang et al.
CELL CYCLE (2019)
Even Cancer Cells Watch Their Cholesterol!
Romain Riscal et al.
MOLECULAR CELL (2019)
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Sung-Hwan Moon et al.
CELL (2019)
CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis
Zhijuan Liang et al.
CELL CYCLE (2019)
The interplay of Patched, Smoothened and cholesterol in Hedgehog signaling
Ao Hu et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
27-Hydroxycholesterol enhanced osteoclastogenesis in lung adenocarcinoma microenvironment
Lishan Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition
Christopher E. Mahoney et al.
NATURE COMMUNICATIONS (2019)
Hepatocyte-generated 27-hydroxycholesterol promotes the growth of melanoma by activation of estrogen receptor alpha
Wei Tian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud F. Tavazoie et al.
CELL (2018)
Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis
Bo Wang et al.
CELL STEM CELL (2018)
The impact of 27-hydroxycholestero on endometrial cancer proliferation
Douglas A. Gibson et al.
ENDOCRINE-RELATED CANCER (2018)
Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial
Teemu J. Murtola et al.
EUROPEAN UROLOGY (2018)
Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway
Hyeon Jeong Lee et al.
MOLECULAR CANCER RESEARCH (2018)
Evaluation of the Cytotoxic and Autophagic Effects of Atorvastatin on MCF-7 Breast Cancer Cells
Tugba Alarcon Martinez et al.
BALKAN MEDICAL JOURNAL (2018)
Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
Yifan Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Activation of LXR?/ by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Soochi Kim et al.
BMC CANCER (2018)
Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
Jessie Qiaoyi Liang et al.
NATURE COMMUNICATIONS (2018)
Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer
Signe Benzon Larsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling
Xu Xiao et al.
MOLECULAR CELL (2017)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan et al.
NATURE (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia
E. J. Gallagher et al.
ONCOGENE (2017)
CHOLESTEROL SENSING Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex
Brian M. Castellano et al.
SCIENCE (2017)
The Role of Oxysterols in Human Cancer
Alzbeta Kloudova et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
Amy E. Baek et al.
NATURE COMMUNICATIONS (2017)
Membrane cholesterol access into a G-protein-coupled receptor
Ramon Guixa-Gonzalez et al.
NATURE COMMUNICATIONS (2017)
Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis
Cristina Enriquez-Cortina et al.
ONCOTARGET (2017)
MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells
Xiuxing Wang et al.
CANCER RESEARCH (2017)
25-Hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells
Li Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway
Tingting Wang et al.
ONCOTARGET (2016)
Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome
Qianming Du et al.
BIOCHEMICAL PHARMACOLOGY (2016)
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
Genaro R. Villa et al.
CANCER CELL (2016)
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice
Claudia Lanterna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Kristen Marie Sanfilippo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Oxysterol binding protein-related protein 8 mediates the cytotoxicity of 25-hydroxycholesterol
Jiwei Li et al.
JOURNAL OF LIPID RESEARCH (2016)
Drugging ACAT1 for Cancer Therapy
Javier Garcia-Bermudez et al.
MOLECULAR CELL (2016)
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang et al.
NATURE (2016)
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
Semir Beyaz et al.
NATURE (2016)
Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer
J. Li et al.
ONCOGENE (2016)
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development
Matias Soncini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer
Rebecca Swan et al.
ONCOTARGET (2016)
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer
David N. Brown et al.
SCIENTIFIC REPORTS (2016)
New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats
Chunchun Ding et al.
SCIENTIFIC REPORTS (2016)
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
NATURE REVIEWS CANCER (2016)
Elevated Levels of StAR-Related Lipid Transfer Protein 3 Alter Cholesterol Balance and Adhesiveness of Breast Cancer Cells Potential Mechanisms Contributing to Progression of HER2-Positive Breast Cancers
Boris Vassilev et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Cholesterol lowering: role in cancer prevention and treatment
Toshiyuki Murai
BIOLOGICAL CHEMISTRY (2015)
NPC1L1 knockout protects against colitis-associated tumorigenesis in mice
Jianming He et al.
BMC CANCER (2015)
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis
Colin A. Flaveny et al.
CANCER CELL (2015)
Obesity promotes colonic stem cell expansion during cancer initiation
V. DeClercq et al.
CANCER LETTERS (2015)
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
Fabiola Bovenga et al.
CELL METABOLISM (2015)
Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells
Urosh Vilimanovich et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells
Jessica Finlay-Schultz et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2015)
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
Maria Feldt et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
Fabienne Guillaumond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
Federica Maione et al.
SCIENTIFIC REPORTS (2015)
Apolipoprotein A-I and Cancer
Maryam Zamanian-Daryoush et al.
FRONTIERS IN PHARMACOLOGY (2015)
Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation
Nora Pencheva et al.
CELL (2014)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
LXR Agonist Regulates the Carcinogenesis of PCa via the SOCS3 Pathway
Weihua Fu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study
Seung Tae Kim et al.
EUROPEAN JOURNAL OF CANCER (2014)
Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport
Omer F. Kuzu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Antiproliferative Effects and Mechanisms of Liver X Receptor Ligands in Pancreatic Ductal Adenocarcinoma Cells
Nicholes R. Candelaria et al.
PLOS ONE (2014)
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
Behzad Yeganeh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA: cholesterol acyltransferase 1
K. Yamanaka et al.
CELL DEATH & DISEASE (2014)
Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling
Ren Sheng et al.
NATURE COMMUNICATIONS (2014)
Cholesterol Regulates Syntaxin 6 Trafficking at trans-Golgi Network Endosomal Boundaries
Meritxell Reverter et al.
CELL REPORTS (2014)
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
Olof Bjarnadottir et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
On the role of 25-hydroxycholesterol Synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment
Gerald Eibinger et al.
EXPERIMENTAL CELL RESEARCH (2013)
Oxysterol receptors and their therapeutic applications in cancer conditions
Hugues De Boussac et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78
Mehdi Hammadi et al.
FASEB JOURNAL (2013)
The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
Maryam Zamanian-Daryoush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma
Apinya Jusakul et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Role of ABC transporters in lipid transport and human disease
Elizabeth J. Tarling et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Qian Wu et al.
CELL REPORTS (2013)
Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development
Christiane Danilo et al.
BREAST CANCER RESEARCH (2013)
Liver x receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism
Trang Nguyen-Vu et al.
BREAST CANCER RESEARCH (2013)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
p53 and cancer stem cells The mevalonate connexion
Christophe Ginestier et al.
CELL CYCLE (2012)
Control of the immune system by oxysterols and cancer development
Catia Traversari et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Hydrophobic statins induce autophagy and cell death in human rhabdomyosarcoma cells by depleting geranylgeranyl diphosphate
Makoto Araki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Targeting the PI3K signaling pathway in cancer therapy
Chandra Bartholomeusz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Anticancer Activity of the Cholesterol Exporter ABCA1 Gene
Bradley Smith et al.
CELL REPORTS (2012)
Role of Cholesterol in the Development and Progression of Breast Cancer
Gemma Llaverias et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Ji-Youn Han et al.
CLINICAL CANCER RESEARCH (2011)
An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway
Deliang Guo et al.
CANCER DISCOVERY (2011)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?
Gerhardt Attard et al.
CANCER CELL (2009)
The oxysterol receptor LXR inhibits proliferation of human breast cancer cells
Lise-Lotte Vedin et al.
CARCINOGENESIS (2009)
Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells
Steven E. Trasino et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Hydrophobic statins induce autophagy in cultured human rhabdomyosarcoma cells
Makoto Araki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
Joan Montero et al.
CANCER RESEARCH (2008)
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Thomas Porstmann et al.
CELL METABOLISM (2008)
Spatiotemporal Analysis of Differential Akt Regulation in Plasma Membrane Microdomains
Xinxin Gao et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor
Haibiao Gong et al.
MOLECULAR ENDOCRINOLOGY (2007)
The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells
Chih-pin Chuu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Cholesterol is required for efficient endoplasmic reticulum-to-Golgi transport of secretory membrane proteins
A Ridsdale et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells
J Fukuchi et al.
CANCER RESEARCH (2004)
Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia
S Meshinchi et al.
BLOOD (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Oxysterols: Modulators of cholesterol metabolism and other processes
GJ Schroepfer
PHYSIOLOGICAL REVIEWS (2000)
分享论文
